Innoveren Scientific Inc. (IVRN)

0.0200 0.0000 (0.00%) At close: 11:46AM EDT

Innoveren Scientific Inc.

201 East Kennedy Blvd
Suite 700
Tampa, FL 33602
United States
844 633 6839
https://innoverenscientific.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 2

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Michael W. Yurkowsky	CEO & Director	180k	N/A	1972
Mr. Jeremy D. Daniel	Chief Financial Officer	200k	N/A	1977
Dr. Tanya Rhodes Ph.D.	Chief Scientific Officer	252k	N/A	1961
Mr. Jeffery Wright CPA, CPA	Controller & Principal Accounting Officer	N/A	N/A	1983

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Innoveren Scientific Inc., a medical bioscience company that develops technology in regenerative medicine for limb salvage. It is also developing immunotherapies for ovarian cancer, pancreatic cancer, and mesothelioma. The company was formerly known as H-CYTE, Inc. and changed its name to Innoveren Scientific Inc. in July 2023. The company is headquartered in Tampa, Florida.

Corporate governance

Innoveren Scientific Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.